NO20042057L - Fosfonsyreforbindelser som inhibitorer av serinproteaser - Google Patents

Fosfonsyreforbindelser som inhibitorer av serinproteaser

Info

Publication number: NO20042057L
Authority: NO; Norway
Prior art keywords: inhibitors; phosphonic acid; acid compounds; serine proteases; proteases
Prior art date: 2001-10-19

Application number

NO20042057A

Other languages

English (en)

Norwegian (no)

Inventor

Bruce E Maryanoff

Michael Nicholas Greco

Harold R Almond

Lawrence De Garavilla

Michael J Hawkins

Yun Qian

Donald Gilmore Walker

Sergio Cesco-Cancian

Christopher Norman Nilsen

Mitul N Patel

Michael J Humora

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-19

Filing date

2004-05-18

Publication date

2004-05-18

2004-05-18 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2004-05-18 Publication of NO20042057L publication Critical patent/NO20042057L/no

Links

102000012479 Serine Proteases Human genes 0.000 title 1
108010022999 Serine Proteases Proteins 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
150000003009 phosphonic acids Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3882—Arylalkanephosphonic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Obesity (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Otolaryngology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

NO20042057A 2001-10-19 2004-05-18 Fosfonsyreforbindelser som inhibitorer av serinproteaser NO20042057L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US33034301P	2001-10-19	2001-10-19
PCT/US2002/033206 WO2003035654A1 (fr)	2001-10-19	2002-10-17	Composes d'acide phosphonique utilises comme inhibiteurs de serine proteases

Publications (1)

Publication Number	Publication Date
NO20042057L true NO20042057L (no)	2004-05-18

Family

ID=23289339

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042057A NO20042057L (no)	2001-10-19	2004-05-18	Fosfonsyreforbindelser som inhibitorer av serinproteaser

Country Status (27)

Country	Link
US (1)	US20030195172A1 (fr)
EP (1)	EP1438316B1 (fr)
JP (1)	JP4423033B2 (fr)
KR (2)	KR20100074322A (fr)
CN (1)	CN100506831C (fr)
AR (1)	AR037245A1 (fr)
AT (1)	ATE330961T1 (fr)
AU (1)	AU2002356818C1 (fr)
BR (1)	BR0213961A (fr)
CA (1)	CA2464111C (fr)
CY (1)	CY1105166T1 (fr)
DE (1)	DE60212675T2 (fr)
DK (1)	DK1438316T3 (fr)
ES (1)	ES2266634T3 (fr)
HU (1)	HUP0600339A2 (fr)
IL (2)	IL161476A0 (fr)
ME (1)	MEP48708A (fr)
MX (1)	MXPA04003707A (fr)
MY (1)	MY133586A (fr)
NO (1)	NO20042057L (fr)
NZ (1)	NZ532372A (fr)
PL (1)	PL209032B1 (fr)
PT (1)	PT1438316E (fr)
RS (1)	RS50944B (fr)
RU (1)	RU2311421C2 (fr)
WO (1)	WO2003035654A1 (fr)
ZA (1)	ZA200403824B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7459461B2 (en)	2001-10-19	2008-12-02	Ortho-Mcneil Pharmaceutical, Inc.	Phosphonic acid compounds as inhibitors of serine proteases
US7601847B2 (en)	2004-10-26	2009-10-13	Wyeth	Preparation and purification of 4-(indazol-3-yl)phenols
WO2006059801A1 (fr)	2004-12-02	2006-06-08	Asubio Pharma Co., Ltd.	Compose cyclique a 7 chainons, procede de production et utilisation medicinale de celui-ci
JP4728350B2 (ja) *	2005-01-06	2011-07-20	シェーリングコーポレイション	ケトンアミドの調製
EP1982186A2 (fr) *	2006-01-12	2008-10-22	Janssen Pharmaceutica, N.V.	Methode de traitement de slpi par chymase
BRPI0712721A2 (pt)	2006-05-31	2012-11-20	Asubio Pharma Co Ltd	composto de anel de 7 membros e mÉtodo de produÇço e aplicaÇço farmacÊutica do mesmo
UY31398A1 (es) *	2007-10-16	2009-04-30		Proceso para sintetizar compuestos de ácido fosfónico y posfínico
JP6011621B2 (ja)	2012-07-24	2016-10-19	富士通株式会社	無線端末、無線基地局、無線通信システムおよび無線通信方法
CN107353305A (zh) *	2017-07-12	2017-11-17	浙江普洛得邦制药有限公司	一种噁唑烷酮类抗菌药物的三羟甲基氨基甲烷盐及其晶型a、制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5508273A (en) *	1993-12-30	1996-04-16	Ortho Pharmaceutical Corporation	Substituted phosphonic acids and derivatives useful in treating bone wasting diseases
WO1997003679A1 (fr) *	1995-07-17	1997-02-06	Cephalon, Inc.	Inhibiteurs de proteases a cysteine et serine, contenant du phosphore
DE19750002A1 (de) *	1997-11-12	1999-05-20	Solvay Pharm Gmbh	Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

2002
- 2002-10-17 CA CA2464111A patent/CA2464111C/fr not_active Expired - Fee Related
- 2002-10-17 EP EP02802153A patent/EP1438316B1/fr not_active Expired - Lifetime
- 2002-10-17 PT PT02802153T patent/PT1438316E/pt unknown
- 2002-10-17 JP JP2003538169A patent/JP4423033B2/ja not_active Expired - Fee Related
- 2002-10-17 WO PCT/US2002/033206 patent/WO2003035654A1/fr not_active Ceased
- 2002-10-17 AT AT02802153T patent/ATE330961T1/de active
- 2002-10-17 DK DK02802153T patent/DK1438316T3/da active
- 2002-10-17 NZ NZ532372A patent/NZ532372A/en not_active IP Right Cessation
- 2002-10-17 MX MXPA04003707A patent/MXPA04003707A/es active IP Right Grant
- 2002-10-17 KR KR1020107011999A patent/KR20100074322A/ko not_active Withdrawn
- 2002-10-17 DE DE60212675T patent/DE60212675T2/de not_active Expired - Lifetime
- 2002-10-17 CN CNB028250982A patent/CN100506831C/zh not_active Expired - Fee Related
- 2002-10-17 AU AU2002356818A patent/AU2002356818C1/en not_active Ceased
- 2002-10-17 BR BR0213961-8A patent/BR0213961A/pt not_active Application Discontinuation
- 2002-10-17 IL IL16147602A patent/IL161476A0/xx unknown
- 2002-10-17 RS YUP-333/04A patent/RS50944B/sr unknown
- 2002-10-17 ME MEP-487/08A patent/MEP48708A/xx unknown
- 2002-10-17 HU HU0600339A patent/HUP0600339A2/hu unknown
- 2002-10-17 ES ES02802153T patent/ES2266634T3/es not_active Expired - Lifetime
- 2002-10-17 RU RU2004111784/04A patent/RU2311421C2/ru not_active IP Right Cessation
- 2002-10-17 KR KR1020047005810A patent/KR101011175B1/ko not_active Expired - Fee Related
- 2002-10-17 PL PL373860A patent/PL209032B1/pl not_active IP Right Cessation
- 2002-10-17 US US10/273,208 patent/US20030195172A1/en not_active Abandoned
- 2002-10-21 MY MYPI20023912A patent/MY133586A/en unknown
- 2002-10-21 AR ARP020103969A patent/AR037245A1/es unknown
2004
- 2004-04-18 IL IL161476A patent/IL161476A/en not_active IP Right Cessation
- 2004-05-18 NO NO20042057A patent/NO20042057L/no not_active Application Discontinuation
- 2004-05-18 ZA ZA200403824A patent/ZA200403824B/en unknown
2006
- 2006-08-23 CY CY20061101180T patent/CY1105166T1/el unknown

Also Published As

Publication number	Publication date
NZ532372A (en)	2007-07-27
AU2002356818B2 (en)	2009-02-26
AR037245A1 (es)	2004-11-03
CN100506831C (zh)	2009-07-01
RU2311421C2 (ru)	2007-11-27
DK1438316T3 (da)	2006-10-16
MY133586A (en)	2007-11-30
DE60212675D1 (de)	2006-08-03
RS50944B (sr)	2010-08-31
RS33304A (sr)	2006-12-15
ES2266634T3 (es)	2007-03-01
HUP0600339A2 (en)	2006-08-28
IL161476A0 (en)	2004-09-27
ZA200403824B (en)	2005-09-13
CA2464111A1 (fr)	2003-05-01
IL161476A (en)	2009-09-01
EP1438316A1 (fr)	2004-07-21
KR20040060941A (ko)	2004-07-06
CN1604904A (zh)	2005-04-06
KR20100074322A (ko)	2010-07-01
JP4423033B2 (ja)	2010-03-03
ATE330961T1 (de)	2006-07-15
KR101011175B1 (ko)	2011-01-26
RU2004111784A (ru)	2005-10-20
EP1438316B1 (fr)	2006-06-21
JP2005537217A (ja)	2005-12-08
MXPA04003707A (es)	2005-04-08
PL209032B1 (pl)	2011-07-29
PT1438316E (pt)	2006-10-31
CY1105166T1 (el)	2010-03-03
BR0213961A (pt)	2004-08-31
WO2003035654A1 (fr)	2003-05-01
PL373860A1 (en)	2005-09-19
HK1065802A1 (en)	2005-03-04
US20030195172A1 (en)	2003-10-16
CA2464111C (fr)	2013-03-12
AU2002356818C1 (en)	2009-10-22
MEP48708A (en)	2011-02-10
DE60212675T2 (de)	2007-06-28

Legal Events

Date	Code	Title	Description
2013-05-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20041180L (no)	2004-03-19	Pyrrolopyrimidiner som midler for inbibering av cysteinprotaser
DK1383731T3 (da)	2009-12-07	Biarylforbindelser som serinproteaseinhibitorer
SE0701538L (sv)	2007-06-26	Azaspiroalkanderivat som hämmare av metalloproteaser
NO20043158L (no)	2004-09-16	Substituerte kinazolinderivater som inhibitorer av aurorakinaser
NO20043102L (no)	2004-07-20	Fjerning av sure gasser
NO20033399D0 (no)	2003-07-30	Eterderivater anvendelige som inhibitorer av PDE4-isoenzymer
ES2571219T8 (es)	2025-05-16	Formulación de compuestos de ácido borónico
NO20014837D0 (no)	2001-10-04	Pyrazolsammensetninger nyttige som inhibitorer av ERK
NO20004696L (no)	2000-09-20	Kinoloner som serinproteaseinhibitorer
NO20043726L (no)	2004-11-08	Heteroarylforbindelser anvendelige som inhibitorer av GSK-3
DK1132570T3 (da)	2004-08-02	Sammensætninger til syrebehandling af borebrönde
NO20034042D0 (no)	2003-09-12	Metallproteinase-inhibitorer
AU2002340031A1 (en)	2003-04-14	Compounds useful as reversible inhibitors of cysteine proteases
NO20034032D0 (no)	2003-09-11	Metallproteinase-inhibitorer
DK1458447T3 (da)	2010-01-18	Kombination af cytokrom-p450-beroende proteasinhibitorer
WO2006047528A3 (fr)	2007-03-01	Pyrazolobenzamides et leurs derives en tant qu'inhibiteurs du facteur xa
NO20042679L (no)	2004-06-25	Inhibitorer av cytosolisk fosfolipase A2
NO20042057L (no)	2004-05-18	Fosfonsyreforbindelser som inhibitorer av serinproteaser
DK1353930T3 (da)	2004-12-06	Fremgangsmåde til fremstilling af N-phosphonomethyliminodieddikesyre
WO2004094441A3 (fr)	2005-10-13	Nouveaux composes d'acide phosphonique utilises comme inhibiteurs des serine proteases
NO20023921D0 (no)	2002-08-19	Derivater av thiazepinylhydroksamisk syre som inhibitorer av matriks metalloproteinase
NO20024481D0 (no)	2002-09-19	Difluorbutyrsyre metalloproteaseinhibitorer
WO2004108892A3 (fr)	2005-02-17	$g(a)-aminoacides, $g(b)-aminoacides, diaminoalkyle contenant 1,1-disubstitue cycloalkyle, glycinamidyle, sulfonyl-amidino-, et tetrahydropyrimidinyle et leurs derives utilises comme inhibiteurs du facteur xa
SE0102921D0 (sv)	2001-08-30	Pharmaceutically useful compounds
EP1551794A4 (fr)	2006-05-17	Composes aniline a substitution ureido utiles comme inhibiteurs de serines proteases